Episode
What Most Favored Nation Drug Pricing Would Mean for the US
- Podcast
- A Health Podyssey
- Published
- Apr 14, 2026
- Duration seconds
- 1435
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/364cdcdb
Actions
POST https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/what-most-favored-nation-drug-pricing-would-mean-for-the-us/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/a-health-podyssey-1366621/what-most-favored-nation-drug-pricing-would-mean-for-the-us.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing , weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. Order the April 2026 issue of Health Affairs .